ILMN Stock — Price, Charts & Analysis

Illumina, Inc. (ILMN) has a trailing P/E of 35.10x and a forward P/E of 33.63x. This places ILMN in a premium earnings multiple territory based on the valuation data currently available on Worldtickers.

ILMN trades with 35.10x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether ILMN looks overvalued or undervalued.

ILMN's P/E of 35.10x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

ILMN's trailing EPS is $5.84 and forward EPS is $6.10. Reported earnings growth is -9.40%, which helps show current profit momentum.

EPS, or earnings per share, shows how much profit Illumina, Inc. generated for each share. ILMN's trailing EPS is $5.84, and investors usually prefer EPS that is positive and growing over time.

Illumina, Inc. has a market cap of $30.95B, making ILMN a large-cap stock based on the current market value shown on Worldtickers.

ILMN's latest stock price on Worldtickers is $205.00. The latest move is $16.71 or 8.87%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

ILMN's quote includes a latest price of $205.00. The market open is $193.85. Previous close is $188.29. The intraday range is $192.68 to $205.16.

ILMN is up in the latest quote, with a move of $16.71 or 8.87%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

ILMN generated $4.49B in trailing revenue. Revenue growth is 9.40%, which helps show whether demand is expanding or slowing.

ILMN's revenue growth is 9.40%, which is a positive demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

Yes, ILMN shows positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is $824.00M.

Gross margin is 67.93%. Margins show how efficiently Illumina, Inc. turns revenue into profit.

Illumina, Inc. carries $2.53B and holds $1.17B in cash.

ILMN holds $1.17B on its balance sheet.

ILMN's book value per share is $18.80.

Institutions hold 105.90% of ILMN shares. Insiders hold 0.21% of shares. Ownership mix helps investors understand how much of Illumina, Inc. is held by professional investors and company insiders.

ILMN has 151M shares outstanding. Float shares are 148.48M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for ILMN, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for ILMN is $6.10. Earnings growth is -9.40%. Revenue growth is 9.40%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

ILMN's trailing EPS is $5.84. Forward EPS is $6.10. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

ILMN is in the Healthcare sector. Its earnings multiple is 35.10x. Its latest displayed growth metric is 9.40%. Compare these figures with sector peers before deciding whether Illumina, Inc. is stronger or weaker than average.

ILMN trades at $205.00. The stock trades at 35.10x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Illumina, Inc.'s fundamentals.

ILMN risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is 1.46, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

ILMN should be compared with companies in Diagnostics & Research. Its earnings multiple is 35.10x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

Illumina, Inc. (ILMN) operates in Healthcare, specifically Diagnostics & Research. Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of in

ILMN trades on NasdaqGS. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

ILMN stock is priced in USD on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

Illumina, Inc.'s official website listed on Worldtickers is investor.illumina.com/phoenix.zhtml?c=121127&p=IROL-irhome. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

Illumina, Inc. employs about 8.6K people based on the latest company profile data available on Worldtickers. Workforce size helps investors understand company scale and operating complexity.

Illumina, Inc. is headquartered in San Diego, CA, United States. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

ILMN is in the Healthcare sector and the Diagnostics & Research industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

ILMN has traded between $88.00 and $207.00 over the past 52 weeks. At $205.00, it is 0.97% below the high and 132.95% above the low. The 52-week range helps gauge long-term price momentum.

ILMN is above both its 50-day and 200-day moving averages, which is a common uptrend signal. Its 50-day moving average is $185.34 and its 200-day moving average is $146.02.

ILMN's RSI is 61.61. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

ILMN's latest RSI reading is 61.61, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for ILMN is near $186.64. Key resistance is near $207.00. Breaks above resistance or below support can change the short-term technical setup.

ILMN's nearest reported support level is $186.64. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

ILMN's nearest reported resistance level is $207.00. A breakout above resistance can improve momentum, especially when volume confirms the move.

ILMN trades about 1.94M shares daily on average. The latest displayed volume is 2.09M shares. Volume helps show liquidity and whether trading interest is unusually high or low.

ILMN's MACD is -0.64, which is a negative momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

ILMN is above both its 50-day and 200-day moving averages, which is a common uptrend signal. RSI is 61.61 (neutral). MACD is bearish. Nearest support is around $186.64. Resistance is around $207.00. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is $195.43 (4.90% from price). MA50 is $185.34 (10.61% from price). MA200 is $146.02 (40.39% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. ILMN's MA20 is $195.43. MA50 is $185.34. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

ILMN's pivot is near $189.55. Support is near $186.64. Resistance is near $207.00. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for ILMN is near $195.11. These levels help define risk and possible follow-through zones after a breakout or breakdown.

ILMN's Bollinger range is roughly $184.68 to $206.19. Band width is near 11.01%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

ILMN's ATR-based typical daily range is about 3.81%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 2.09M shares. Average volume is about 1.94M shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

ILMN's all-time high shown on Worldtickers is $540.63. Its all-time low is $0.83. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

ILMN has a beta of 1.46, meaning it has historically been more volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.